AAV gene therapy (Sarepta/Columbia University)

N/A

Report date: 2025/01/26 18:05:12

Base Information

Drug NameAAV gene therapy (Sarepta/Columbia University)
Drug Alias NameAAV gene therapy (Sarepta/StrideBio)
ClassificationBiologics
Mechanisms of ActionMusculoskeletal system modulators
TargetsUpdating
Therapy Area/IndicationsMuscular Dystrophy, Emery-Dreifuss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSarepta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSarepta Therapeutics IncColumbia University
Inactive CompaniesStridebio Inc
Active IndicationsMuscular Dystrophy, Emery-Dreifuss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A